ROCKVILLE, Md. — The American Society of Human Genetics (ASHG) has officially unveiled its 2026 Professional Awards, a prestigious slate of accolades recognizing seven individuals whose groundbreaking contributions have redefined the boundaries of human genetics and genomics. From pioneering gene-editing therapies that offer hope for rare diseases to developing educational frameworks that address the social complexities of ancestry, this year’s cohort represents the intellectual vanguard of modern medicine.
The honorees will be formally recognized during the ASHG 2026 Annual Meeting, scheduled for October 20–24 in Montréal. The ceremony serves as a highlight of the global scientific calendar, celebrating achievements in research, education, mentorship, and public service that continue to translate complex genomic data into tangible improvements for human health.
The 2026 Honorees: A Legacy of Innovation
The ASHG awards recognize a diverse range of expertise, reflecting the interdisciplinary nature of 21st-century genomics.
ASHG Lifetime Achievement Award: Dr. Yusuke Nakamura
Dr. Yusuke Nakamura, President of the National Institutes of Biomedical Innovation, Health and Nutrition in Japan, has been honored with the Lifetime Achievement Award. His career spans the transition from the infancy of molecular biology to the era of precision medicine. Dr. Nakamura’s foundational work in identifying Variable Number Tandem Repeat (VNTR) markers was instrumental in the birth of the positional cloning era. His subsequent research into colorectal cancer genetics and his stewardship of BioBank Japan have provided the global scientific community with an essential infrastructure for understanding complex diseases.
ASHG Leadership Award: Dr. Aravinda Chakravarti
As the Director of the Center for Human Genetics and Genomics at NYU Grossman School of Medicine, Dr. Aravinda Chakravarti has been recognized for his profound influence on the field. A veteran of the Human Genome Project, the HapMap project, and the 1000 Genomes Project, Dr. Chakravarti has consistently bridged the gap between raw statistical data and biological reality. His work on cystic fibrosis and non-coding genetic variation has been pivotal in shaping our modern understanding of how genes influence health and disease.
ASHG Scientific Achievement Award: Dr. Wendy Chung
Dr. Wendy Chung, Chief of Pediatrics at Boston Children’s Hospital, receives the Scientific Achievement Award for her transformative work in clinical genetics. Over the last decade, Dr. Chung has identified more than 60 genes associated with human disease, ranging from neurodevelopmental disorders to metabolic conditions. Her ability to synthesize laboratory discoveries into clinical protocols has revolutionized newborn sequencing and population-based screening, directly benefiting patients and families worldwide.
ASHG Early Career Award: Dr. Rebecca Ahrens-Nicklas
The Early Career Award goes to Dr. Rebecca Ahrens-Nicklas of the Children’s Hospital of Philadelphia (CHOP). Dr. Ahrens-Nicklas is at the forefront of the "precision medicine" revolution, most notably for her work in delivering the world’s first personalized in vivo CRISPR therapy for an infant with an ultra-rare metabolic disease. Her success serves as a proof-of-concept for the future of individualized genomic medicine.
ASHG Advocacy Award: Roxanne Khamsi
Recognizing the importance of public understanding, the ASHG has awarded journalist Roxanne Khamsi for her exceptional science communication. A contributing writer for The Atlantic, Khamsi has spent two decades dissecting the intersection of genetics and the human experience. Her work, including her recent book Beyond Inheritance, challenges reductive narratives about genetic mutations, ensuring that the public understands the nuance and humanity behind the science.
ASHG Education Award: Dr. Robbee Wedow
Dr. Robbee Wedow, an Assistant Professor at Purdue University, is honored for his work on the "Humane Genetics Curriculum" (HGC). In an era where discussions surrounding race, ancestry, and genetics are increasingly polarized, Dr. Wedow’s framework provides educators with the tools to teach these subjects with scientific rigor and social empathy. His work ensures that the next generation of leaders in law, medicine, and public policy can engage with genetic evidence responsibly.
ASHG Mentorship Award: Dr. Nancy B. Spinner
Dr. Nancy B. Spinner, currently the Associate Chair of Genomic Strategy at Northwell Health, is celebrated for her long-standing commitment to training the next generation of scientists. With a 35-year tenure at CHOP and the University of Pennsylvania, Dr. Spinner has mentored dozens of laboratory directors and faculty members. Her legacy is one of cultivating a collaborative, collegial, and inclusive scientific environment.
Chronology of Scientific Impact
The evolution of these award-winning careers mirrors the rapid progression of the genomics field itself:
- 1990s – The Positional Cloning Era: Led by figures like Dr. Yusuke Nakamura, researchers began mapping disease genes by identifying markers throughout the genome, setting the stage for the identification of hereditary cancer markers.
- 2000s – The Genomic Mapping Era: With the completion of the Human Genome Project and the initiation of the HapMap Project, leaders like Dr. Aravinda Chakravarti established the collaborative foundations necessary to study population genetics and common disease variants.
- 2010s – The Translational Era: Clinicians such as Dr. Wendy Chung began moving the needle from "discovery" to "clinical application," integrating genomic screening into standard pediatric care and rare disease diagnosis.
- 2020s – The Precision and Ethical Era: The current decade is defined by the integration of CRISPR-based therapeutics (Dr. Ahrens-Nicklas), the application of data science to social constructs of race and ancestry (Dr. Wedow), and a more sophisticated public discourse regarding genetic determinism (Roxanne Khamsi).
Supporting Data: The Scale of Genomic Progress
The impact of these individuals is best measured by the sheer scale of the initiatives they have led. BioBank Japan, for example, has provided a massive repository of genetic data that allows for the identification of rare variants that would have been invisible a generation ago. Similarly, the work of the Human Genome Project, in which Dr. Chakravarti played a key role, produced a foundational map that serves as the "reference" for nearly all genomic research conducted today.
In clinical settings, Dr. Chung’s work has directly resulted in the diagnostic odyssey for families with rare disorders being cut from years to months—or sometimes weeks. These clinical outcomes demonstrate that genomics is no longer a purely academic pursuit; it is a critical diagnostic and therapeutic tool.
Official Responses and Vision for the Future
"ASHG is honored to recognize this exceptional group of awardees," said Dr. Susan A. Slaugenhaupt, President of the American Society of Human Genetics. "Their collective work demonstrates the many ways human genetics and genomics can advance science and serve society. Each honoree has helped shape a stronger, more collaborative, and more impactful field."
Dr. Slaugenhaupt emphasized that these awards are not merely historical markers, but indicators of the future. "Their achievements inspire our community and reflect the promise of genetics to improve lives around the world," she added. The society views these individuals as key pillars in the ongoing effort to ensure that genomic research remains equitable, accessible, and ethically sound.
Implications for the Future of Human Health
The recognition of these seven individuals carries significant implications for the future of healthcare. As we move toward an era where genome editing and personalized molecular diagnostics become standard, the work of these awardees provides a roadmap for success.
- Therapeutic Breakthroughs: The success of Dr. Ahrens-Nicklas signals a shift where "orphan" or ultra-rare diseases—previously considered untreatable—may now have viable genetic interventions.
- Educational Equity: By integrating sociology and ethics into the study of genetics, as Dr. Wedow does, the field is proactively addressing the historical misuse of genetic data, ensuring a more inclusive future for genomic medicine.
- Public Literacy: Through the work of communicators like Roxanne Khamsi, the scientific community is learning to better navigate the "hype" surrounding genetics, fostering a more scientifically literate public that can make informed decisions about their own genetic health.
- Institutional Mentorship: The emphasis on mentorship, exemplified by Dr. Spinner, ensures that the scientific workforce remains resilient and diverse, capable of carrying these complex research projects forward into the next decade.
As the scientific community prepares to gather in Montréal this October, the focus will not only be on the technical successes of the past but on the collaborative, ethical, and inclusive future these awardees represent. For those interested in the unfolding narrative of human genetics, registration for the ASHG 2026 Annual Meeting is currently open, offering a front-row seat to the next phase of this scientific revolution.
About the American Society of Human Genetics (ASHG)
The American Society of Human Genetics (ASHG) is the premier global professional organization for human genetics and genomics. With a membership of nearly 8,000 researchers, clinicians, and genetic counselors, ASHG is committed to the advancement of human health through the scientific exploration of the genome. Through its publications, The American Journal of Human Genetics and Human Genetics and Genomics Advances, and its annual meetings, the society facilitates the exchange of critical knowledge that defines the modern era of medicine.
About the Author
